| Ticker | % Reduced |
|---|---|
| maze therapeutics inc | -33.49 |
| Ticker | $ Sold |
|---|---|
| globalfoundries inc | -132,745,000 |
Matrix Capital Management Company, LP has about 59.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 59.8 |
| Others | 40.2 |
Matrix Capital Management Company, LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 40.2 |
| SMALL-CAP | 40.1 |
| MICRO-CAP | 19.7 |
About 59.8% of the stocks held by Matrix Capital Management Company, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 59.8 |
| Others | 40.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Matrix Capital Management Company, LP has 3 stocks in it's portfolio. AURA proved to be the most loss making stock for the portfolio. ZNTL was the most profitable stock for Matrix Capital Management Company, LP last quarter.
Last Reported on: 13 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AURA | aura biosciences inc | 40.08 | 6,922,870 | 42,783,300 | unchanged | 0.00 | ||
| GFS | globalfoundries inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ZNTL | zentalis pharmaceuticals inc | 19.75 | 13,960,000 | 21,079,600 | unchanged | 0.00 | ||
| maze therapeutics inc | 40.17 | 1,653,680 | 42,880,000 | reduced | -33.49 | |||